Peripheral Neuropathy under Infliximab Therapy: About One Case ()
ABSTRACT
A-TNF
inhibitors are increasingly used in various inflammatory disorders. Multiple
side effects have been reported in recent years, particularly peripheral
neuropathies. We report a case of axonal neuropathy occurring after the start
of treatment with Infliximab. This is a 47 years old patient, followed for
Crohn’s
disease requiring treatment with Infliximab. Twenty-two weeks later, the patient
presented a grade 4 of axonal neuropathy. We concluded to a medicinal sensitive
neuropathy after elimination of other etiologies. Given the severity of the neurological symptoms, we
decided to change the therapeutic class.
Share and Cite:
Hamdoun, F. , Abid, H. , Lahmidani, N. , Yousfi, M. , Benajah, D. , Abkari, M. and Ibrahimi, A. (2020) Peripheral Neuropathy under Infliximab Therapy: About One Case.
Open Journal of Gastroenterology,
10, 242-246. doi:
10.4236/ojgas.2020.109023.
Cited by
No relevant information.